0001209191-20-063314.txt : 20201214 0001209191-20-063314.hdr.sgml : 20201214 20201214184015 ACCESSION NUMBER: 0001209191-20-063314 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201210 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freund John Gordon CENTRAL INDEX KEY: 0001296771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38662 FILM NUMBER: 201387654 MAIL ADDRESS: STREET 1: 125 UNIVERSITY AVE. STREET 2: C/O SKYLINE VENTURES CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC. CENTRAL INDEX KEY: 0001382101 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452441988 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 310 UTAH AVE., SUITE 150 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-392-8412 MAIL ADDRESS: STREET 1: 310 UTAH AVE., SUITE 150 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: SUTRO BIOPHARMA INC DATE OF NAME CHANGE: 20061127 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-10 0 0001382101 SUTRO BIOPHARMA, INC. STRO 0001296771 Freund John Gordon SKYLINE VENTURES 525 UNIVERSITY AVE., SUITE 1350 PALO ALTO CA 94301 1 0 0 0 Common Stock 2020-12-10 4 J 0 118735 0.00 D 0 I By Skyline Venture Management V, LLC Common Stock 2020-12-10 4 J 0 56327 0.00 A 56327 I By partnership The shares reported on this form represent pro rata distributions, and not sales or purchases, of securities by the reporting entity to its partners. These securities are held of record by Skyline Venture Management V, LLC ("Skyline Management"), of which the reporting person, a member of the issuer's board of directors, together with Yasunori Kaneko, are the managing directors, and each may be deemed to share voting and investment power over the securities held by Skyline Management. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. These securities are held of record by the John Freund Family Partnership IV, L.P. /s/ Edward C. Albini as attorney-in-fact for John G. Freund 2020-12-14